Apolipoprotein E alleles and risk of coronary disease - A meta-analysis

被引:478
作者
Wilson, PWF
Schaefer, EJ
Larson, MG
Ordovas, JM
机构
[1] BOSTON UNIV,FRAMINGHAM,MA
[2] TUFTS UNIV,USDA,NUTR CTR,BOSTON,MA 02111
关键词
apolipoproteinE; coronary heart disease; meta-analysis; molecular epidemiology;
D O I
10.1161/01.ATV.16.10.1250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A meta-analysis was undertaken to assess the impact of apolipoprotein E (apo E) alleles (epsilon 2, epsilon 3, and epsilon 4) on coronary disease in 14 published observational studies (9 clinical coronary disease and 5 coronary angiography). In comparison with epsilon 3, the epsilon 4 allele was associated with greater odds for coronary heart disease, and summary estimates of the odds ratios (ORs) and (95% confidence intervals) for both sexes combined were OR=0.98 (0.85-1.14) for epsilon 2 and OR=1.26 (1.13-1.41) for epsilon 4. Separate analyses for men and women showed similar associations. In angiographic studies the relative odds for significant coronary artery disease among both sexes combined was OR=0.76 (0.55-1.05) for epsilon 2 and OR=1.11 (0.88-1.40) for epsilon 4. The overall impression is that epsilon 4 is associated with clinical and coronary disease and that results are similar in men and women.
引用
收藏
页码:1250 / 1255
页数:6
相关论文
共 42 条
[1]   A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS [J].
BERLIN, JA ;
LAIRD, NM ;
SACKS, HS ;
CHALMERS, TC .
STATISTICS IN MEDICINE, 1989, 8 (02) :141-151
[2]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[3]   THE USE OF MEASURED GENOTYPE INFORMATION IN THE ANALYSIS OF QUANTITATIVE PHENOTYPES IN MAN .2. THE ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING LEVELS, VARIABILITY, AND COVARIABILITY OF CHOLESTEROL, BETA-LIPOPROTEIN, AND TRIGLYCERIDES IN A SAMPLE OF UNRELATED INDIVIDUALS [J].
BOERWINKLE, E ;
VISVIKIS, S ;
WELSH, D ;
STEINMETZ, J ;
HANASH, SM ;
SING, CF .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 27 (03) :567-582
[4]  
Breslow NE, 1980, STATISTICAL METHODS, P162
[5]   DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION [J].
BURING, JE ;
OCONNOR, GT ;
GOLDHABER, SZ ;
ROSNER, B ;
HERBERT, PN ;
BLUM, CB ;
BRESLOW, JL ;
HENNEKENS, CH .
CIRCULATION, 1992, 85 (01) :22-29
[6]   FIBRILLOGENESIS IN ALZHEIMERS-DISEASE OF AMYLOID-BETA PEPTIDES AND APOLIPOPROTEIN-E [J].
CASTANO, EM ;
PRELLI, F ;
WISNIEWSKI, T ;
GOLABEK, A ;
KUMAR, RA ;
SOTO, C ;
FRANGIONE, B .
BIOCHEMICAL JOURNAL, 1995, 306 :599-604
[7]   LOGISTIC DISCRIMINANT-ANALYSIS OF LIPIDS AND APOLIPOPROTEINS IN A POPULATION OF CORONARY-BYPASS PATIENTS AND THE SIGNIFICANCE OF APOLIPOPROTEIN-C-III AND APOLIPOPROTEIN-E [J].
CHIVOT, L ;
MAINARD, F ;
BIGOT, E ;
BARD, JM ;
AUGET, JL ;
MADEC, Y ;
FRUCHART, JC .
ATHEROSCLEROSIS, 1990, 82 (03) :205-211
[8]   PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY [J].
COUDERC, R ;
MAHIEUX, F ;
BAILLEUL, S ;
FENELON, G ;
MARY, R ;
FERMANIAN, J .
STROKE, 1993, 24 (05) :661-664
[9]  
CUMMING AM, 1984, CLIN GENET, V25, P310
[10]   GENETIC-BASIS OF LIPOPROTEIN DISORDERS [J].
DAMMERMAN, M ;
BRESLOW, JL .
CIRCULATION, 1995, 91 (02) :505-512